This article relies largely or entirely on a single source .(August 2014) |
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C38H38N4O6 |
Molar mass | 646.744 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Tariquidar (INN/USAN) is a potent P-glycoprotein inhibitor and a substrate of breast cancer protein (BCRP/ABCG2) [1] undergoing research as an adjuvant against multi-drug resistance in cancer.